13F-HR filed by Invus Financial Advisors, LLC
Invus Financial Advisors, LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 8 holding rows worth $329,061,000.
- Accession
- 0001214659-22-002648
- Filer
- CIK 1802978
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 8 entries on the cover page, a total value of $329,061,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $329,061,000 with VALUE read as thousands by filing date, 13F file number 028-19938. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| COUPANG INC | 22266T109 | CL A | 3,164,571 | $92,975,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 1,612,077 | $65,241,000 | thousands by filing date | |
| TABOOLA.COM LTD | M8744T106 | ORD SHS | 7,819,690 | $60,837,000 | thousands by filing date | |
| OYSTER POINT PHARMA INC | 69242L106 | COMMON STOCK | 2,768,586 | $50,554,000 | thousands by filing date | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 350,884 | $26,344,000 | thousands by filing date | |
| IONQ INC COM | 46222L108 | Stock | 1,000,000 | $16,700,000 | thousands by filing date | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,007,575 | $14,811,000 | thousands by filing date | |
| UNITY BIOTECHNOLOGY INC | 91381U101 | COM | 1,094,998 | $1,599,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-22-002648 | this filing | 2022-02-14 | acceptance time not in the bulk data set |